Abacavir Salt (CAS number 188062-50-2) is a significant medication mainly utilized in the treatment of HIV infection and related additional infections . It functions as a nucleoside inhibitor , interfering with the HIV's reproduction cycle. Administered often in combination other AIDS drugs , abacavir plays a critical part in reducing the viral load and improving patient health . Careful HLA testing for the HLA-B*57:01 allele is required prior to start of the therapy to reduce the chance of a serious adverse effect.
Abarelix (183552-38-7): Characteristics and Uses
Abarelix, identified by the Substance Designation 183552-38-7, is a laboratory-created peptide agonist of gonadotropin-releasing hormone (GnRH). This main feature lies in its ability to initially stimulate, then rapidly desensitize GnRH receptors, leading to a significant decrease in sex hormone output . Clinically , abarelix is utilized primarily in the treatment of advanced prostate cancer ; however, studies also explores emerging roles in other hormonal conditions and reproductive health . The agent's makeup allows for targeted receptor interaction .
```text
Abiraterone Acetate (154229-18-2): Synthesis and Analytical Data
The preparation of Abiraterone Acetate, identified by the Chemical Abstracts Service Registry Number 154229-18-2, involves complex multistep organic routes. Several published methods exist, often beginning with Androstadienedione and utilizing controlled oxidation and acetylation steps. A typical process includes protecting group strategies to ensure desired regioselectivity. Analytical data, crucial for assurance control, routinely employs liquid chromatography (HPLC) for determination of content. Nuclear Magnetic Resonance (NMR) analysis confirms the structural identity. Mass measurement delivers molecular weight verification. Other techniques, like infrared (IR) spectroscopy, assist in characterization and are essential for lot release.
- Production Routes
- Quality Control
- Analytical Characterization
```
```text
Understanding the CAS Numbers of Abacavir, Abarelix, and Abiraterone Acetate
Identifying chemical substances accurately is paramount in fields like medicine, research, and manufacturing. A crucial tool for this identification is the Chemical Abstracts Service (CAS) registry number – a unique numerical identifier assigned to every distinct chemical compound. Let's examine the CAS numbers for three significant pharmaceuticals: Abacavir, Abarelix, and Abiraterone Acetate. Knowing these identifiers aids in precise referencing and prevents ambiguity within scientific literature and regulatory documentation. Abacavir, a nucleoside reverse transcriptase inhibitor used to treat HIV, holds the CAS number 60242-78-0. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist employed in prostate cancer treatment, is identified by the CAS number 5490-02-9. Finally, Abiraterone Acetate a CYP17 inhibitor used in metastatic prostate cancer, possesses the CAS number 857342-50-7. Correctly utilizing these numbers ensures clarity and consistency when discussing these medications.
- The Antiretroviral CAS Number: 60242-78-0
- Abarelix CAS Number: 5490-02-9
- Abiraterone Acetate CAS Number: 857342-50-7
```
Key Information on Abacavir Salt, Abarelix Injection , and Abiraterone Acetate
These drugs represent distinct treatments in medicine. Abacavir is a medicine primarily given to combat ALPROSTADIL 745-65-3 HIV illness, often with other antiviral . Abarelix Injection is a drug that works as a hormone blocker , typically prescribed to lower prostate tumors before removal. Lastly, Abiraterone Drug is another treatment given to treat advanced prostate growths, specifically suppressing testosterone synthesis . Always ask a physician for detailed information and instructions regarding any drug.
Drug Analysis: Abacavir, Abarelix, Abiraterone Drug and Their Registration Numbers
Reviewing key pharmaceutical compounds requires some established identification. Particularly, Abacavir Sulfate, used in retroviral treatment, has a Registration ID of 3870-92-6. In the same way, Abarelix, a GnRH antagonist given during male cancer management, exhibits the Chemical Abstracts Service Code 64347-82-2. Finally, Abiraterone Acetate, a medication to metastatic male lesions, is linked with the Registration Reference 864930-63-3. Such codes serve vital tools in correct pharmaceutical referencing as well as study.